retatrutide vs Tirzepatide: 28.7% vs 22.5% (2026) Retatrutide vs Tirzepatide (Research Comparison)

Less community experience and dosing protocols established

doi:10.1016/S0140-6736(14)61682-2

That pattern is not unusual within the wider incretin research category, where gastrointestinal tolerability is often one of the most closely monitored safety areas

In this guide, well explore the pros and cons of each site to help you decide which one might work best for your needs and make your treatment as smooth and effective as possible

The best approach is balanced: keep the metabolic benefits, understand the retinal risk, and monitor the eye appropriately

Others need the additional hormonal leverage that only tirzepatide provides